Industry Updates

Timely Insights for Radiology Professionals

FDA OKs SubtleSYNTH MRI Software

Subtle Medical’s SubtleSYNTH software, cleared by the FDA, uses deep learning to create synthetic STIR images from T1 and T2 contrasts, speeds up MRI acquisition, and is validated for spinal imaging, with plans for expansion funded by a $2.3 million National Institutes of Health grant.

Editor’s Picks

Insights for the Radiology Decision-Maker